活化ＳＴＩＮＧ轉接蛋白之具有膦酸酯鍵之2'3'環二核苷酸

0577633 - ÚOCHB 2024 RIV chi P - Patent Document
Birkuš, Gabriel - Páv, Ondřej - Jandušík, Tomáš - Rosenberg, Ivan - Nencka, Radim
活化ＳＴＩＮＧ轉接蛋白之具有膦酸酯鍵之2'3'環二核苷酸.
[2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein.]
2023. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.02.2023. Patent Number: TWI793231. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
R&D Projects: GA MŠMT(CZ) EF16_019/0000729
Institutional support: RVO:61388963
Keywords : STING * cyclic dinucleotide * agonist
OECD category: Organic chemistry
https://worldwide.espacenet.com/patent/search/family/065244413/publication/TWI793231B?q=TWI793231B

本發明係關於具有通式(J)之2'3'環狀膦酸酯二核苷酸、其醫藥學上可接受之鹽、其醫藥組合物以及該等物質與其他藥劑或藥品之組合。本發明亦係關於該等化合物之用途，其係用於治療或預防可藉由STING蛋白質調節來改善之疾病或病狀，諸如癌症或病毒性、過敏性及發炎性疾病。此外，此等物質可用作疫苗中之佐劑。

The present disclosure relates to 2′3′ cyclic phosphonate dinucleotides of general formula (J), their pharmaceutically acceptable salts, their pharmaceutical composition and combinations of said substances and other medicaments or pharmaceuticals. The disclosure also relates to the use of said compounds for the treatment or prevention of diseases or conditions modifiable by STING protein modulation, such as cancer or viral, allergic and inflammatory diseases. In addition, these substances can be used as adjuvants in vaccines.
Permanent Link: https://hdl.handle.net/11104/0346765